Concepedia

Steven Whitebread

SW

Statistics

Publications

50

Citations

6.6K

H-Index

36

Active since

1986

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Synaptic Research (United States)

University of California, San Francisco

Steven Whitebread is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and drug discovery.

ORCID

Publications per year

1986–2020

50

Publications

50

Large-scale prediction and testing of drug activity on side-effect targets

Eugen Lounkine, Michael J. Keiser, Steven Whitebread et al. · Nature · 2012 · 897 citations · Full text

, , +16

A receptor subtype involved in neuropeptide-Y-induced food intake

Christophe Gerald, Mary W. Walker, Leoluca Criscione et al. · Nature · 1996 · 893 citations

, , +14

Preliminary biochemical characterization of two angiotensin II receptor subtypes

Steven Whitebread, Michèle Mele, B. Kamber et al. · Biochemical and Biophysical Research Communications · 1989 · 778 citations

, , +12

Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.

Marc de Gasparo, Urs R. Joss, Hans-Peter Ramjoué et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 342 citations

, , +16

Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

Andreas Bender, Josef Scheiber, Meir Glick et al. · ChemMedChem · 2007 · 326 citations

, , +15

1–5 of 50